8450 J. Am. Chem. Soc., Vol. 122, No. 35, 2000
Hyldtoft and Madsen
was washed with Et2O (20 mL). The filtrate was stirred with Amberlite
IR-120 (H+) (25 mL) for 1 h to remove hydroxyl protecting groups.
The mixture was transferred onto a column of mixed bed ion-exchange
resin consisting of Amberlite IR-120 (H+) (75 mL) and IRA-400 (OH-)
(75 mL). The column was eluted with H2O (500 mL). The eluate was
concentrated, and the residue purified by flash chromatography.
1,2,3,7,8-Pentadeoxy-D-ribo-oct-1,7-dienitol (7r). Rf ) 0.62 (Et2O).
washed with H2O (20 mL) and the aqueous phase extracted with CH2-
Cl2 (2 × 40 mL). The combined organic phases were dried and
concentrated to a syrup. 13C NMR revealed the formation of 11r and
11â in a ratio of 5:1. Flash chromatography (pentane:Et2O ) 2:1) gave
0.44 g (98%) of 11r and 11â as an inseparable mixture; Rf ) 0.35.
For 11R: 1H NMR (500 MHz, CDCl3): δ 6.25 (m, 1H), 6.04 (ddd,
J ) 6.8, 10.7, 17.1 Hz, 1H), 5.70 (m, 1H), 5.41 (ddd, J ) 1.7, 1.8,
17.1 Hz, 1H), 5.27 (dddd, J ) 1.3, 1.5, 1.6, 10.7 Hz, 1H), 5.08 (septet,
J ) 6.0 Hz, 1H), 4.68 (dt, J ) 0.9, 6.3 Hz, 1H), 3.96 (dd, J ) 6.4, 8.5
Hz, 1H), 3.77 (dt, J ) 2.6, 8.5 Hz, 1H), 2.84 (ddd, J ) 0.9, 2.6, 14.2
Hz, 1H), 2.43 (dd, J ) 9.0, 14.2 Hz, 1H), 1.50 (s, 3H), 1.37 (s, 3H),
1.30 (d, J ) 6.0 Hz, 3H), 1.29 (d, J ) 6.0 Hz, 3H). 13C NMR (50
MHz, CDCl3): δ 167.9, 137.3, 134.2, 127.9, 117.6, 108.5, 80.1, 78.7,
69.3, 68.3, 36.7, 27.7, 25.3, 21.7.
1
mp 84-85 °C (MeOH). [R]D -32.4 (c 1.0, CHCl3). H NMR (500
MHz, CDCl3): δ 6.01 (ddd, J ) 6.6, 10.5, 17.2 Hz, 1H), 5.88 (m,
1H), 5.42 (dt, J ) 1.4, 17.3 Hz, 1H), 5.33 (dt, J ) 1.4, 10.5 Hz, 1H),
5.19-5.23 (m, 2H), 4.33 (ddt, J ) 1.2, 6.1, 6.6 Hz, 1H), 3.72 (ddd, J
) 3.3, 7.2, 8.4, 1H), 3.54 (dd, J ) 5.5, 7.1 Hz, 1H), 2.60 (ddddd, J )
1.4, 1.5, 3.3, 4.7, 14.2 Hz, 1H), 2.34 (s, OH, 3H), 2.28 (ddddd, J )
1.2, 1.3, 8.3, 8.4, 14.1 Hz, 1H). 13C NMR (63 MHz, CDCl3): δ 136.6,
134.3, 118.7, 117.8, 75.1, 74.7, 71.9, 37.9. Anal. Calcd for C8H14O3:
C, 60.74; H, 8.92. Found: C, 60.72; H, 8.97.
1,2,3,7,8-Pentadeoxy-D-arabino-oct-1,7-dienitol (7â). Rf ) 0.60
(Et2O). [R]D +50 (c 0.4, MeOH). 1H NMR (500 MHz, CDCl3): δ 5.95
(ddd, J ) 5.6, 10.7, 17.5 Hz, 1H), 5.85 (m, 1H), 5.41 (dt, J ) 1.3,
17.5 Hz, 1H), 5.29 (dt, J ) 1.3, 10.7 Hz, 1H), 5.17 (dq, J ) 1.7, 11.3
Hz, 1H), 5.14 (dq, J ) 0.9, 11.3 Hz, 1H), 4.36 (dd, J ) 1.2, 5.5 Hz,
1H), 3.92 (m, 1H), 3.50 (m, 1H), 2.61 (bd, J ) 7.7 Hz, 1H), 2.54 (bd,
J ) 6.0 Hz, 1H). 13C NMR (50 MHz, CDCl3): δ 136.1, 133.8, 118.3,
117.4, 75.0, 73.6, 70.1, 37.8.
Acetylation gave 19: Rf ) 0.87 (pentane:Et2O ) 1:1). [R]D +31 (c
0.6, CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.65-5.79 (m, 2H), 5.37
(dt, J ) 1.3, 17.1 Hz, 1H), 5.28-5.33 (m, 2H), 5.19-5.24 (m, 2H),
5.11 (ddd, J ) 1.3, 1.7, 7.0 Hz, 1H), 5.09 (dt, J ) 1.3, 4.7 Hz, 1H),
2.30 (m, 2H), 2.11 (s, 3H), 2.06 (s, 3H), 2.05 (s, 3H). 13C NMR (126
MHz, CDCl3): δ 170.1, 170.0, 169.5, 132.4, 132.3, 120.4, 118.6, 72.5,
72.0, 69.7, 35.5, 20.9. 20.7, 20.7. Anal. Calcd for C14H20O6: C, 59.14;
H, 7.09. Found: C, 59.60; H, 7.38.
For 11â: 13C NMR (50 MHz, CDCl3): δ 167.9, 137.3, 134.1, 127.3,
119.5, 108.5, 80.1, 79.1, 69.3, 68.3, 36.9, 27.1, 24.8, 21.7. Anal. Calcd
for C15H24O5: C, 63.36; H, 8.51. Found: C, 63.30; H, 8.53.
Compounds 11R and 11â were separated after acetylation. For 38:
Rf ) 0.81 (pentane:Et2O ) 2:1). [R]D -11.6 (c 3.0, CHCl3). 1H NMR
(500 MHz, CDCl3): δ 6.18 (m, 1H), 5.85 (dddd, J ) 2.5, 7.8, 10.3,
17.6 Hz, 1H), 5.56 (bs, 1H), 5.36 (ddd, J ) 0.8, 2.3, 17.2 Hz, 1H),
5.24 (ddd, J ) 0.8, 1.2, 10.2 Hz, 1H), 5.06-5.11 (m, 2H), 4.64 (bt, J
) 7.0 Hz, 1H), 4.17 (t, J ) 6.7 Hz, 1H), 2.97 (dd, J ) 2.1, 14.4 Hz,
1H), 2.40 (dd, J ) 8.6, 14.4 Hz, 1H), 1.92 (s, 3H), 1.54 (s, 3H), 1.39
(s, 3H), 1.30 (d, J ) 6.2 Hz, 3H), 1.29 (d, J ) 6.2 Hz, 3H). 13C NMR
(126 MHz, CDCl3): δ 169.5, 165.9, 136.7, 132.6, 127.2, 118.6, 108.9,
78.7, 78.3, 70.0, 68.0, 34.1, 27.4, 25.2, 21.6, 21.6, 20.9. Anal. Calcd
for C17H26O6: C, 62.56; H, 8.03. Found: C, 62.42; H, 7.97.
Reduction of 11R with DIBAL-H followed by acetylation gave 39:
1
Rf ) 0.65 (pentane:Et2O ) 2:1). [R]D -6.4 (c 3.0, CHCl3). H NMR
(500 MHz, CDCl3): δ 5.83 (ddd, J ) 7.3, 10.3, 17.2 Hz, 1H), 5.37
(dt, J ) 1.3, 17.2 Hz, 1H), 5.25 (dt, J ) 1.3, 10.3 Hz, 1H), 5.12 (m,
1H), 4.99-5.03 (m, 2H), 4.65 (t, J ) 7.1 Hz, 1H), 4.61 (d, J ) 13.3
Hz, 1H), 4.54 (d, J ) 13.3 Hz, 1H), 4.21 (t, J ) 6.9 Hz, 1H), 2.56
(bdd, J ) 2.2, 14.6 Hz, 1H), 2.36 (dd, J ) 8.6, 14.6 Hz, 1H), 2.09 (s,
3H), 1.98 (s, 3H), 1.51 (s, 3H), 1.38 (s, 3H). 13C NMR (50 MHz,
CDCl3): δ 170.5, 169.7, 139.4, 132.7, 118.5, 116.1, 108.9, 78.5, 78.0,
70.0, 66.5, 34.9, 27.3, 25.0, 20.9, 20.8. Anal. Calcd for C16H24O6: C,
61.52; H, 7.74. Found: C, 61.47; H, 7.72.
1,2,3,7,8-Pentadeoxy-L-lyxo-oct-1,7-dienitol (8r). Rf ) 0.59 (Et2O).
1
[R]D -22 (c 0.6, MeOH). H NMR (300 MHz, CD3OD): δ 5.79-
5.98 (m, 2H), 5.25 (dt, J ) 1.3, 15.1 Hz, 1H), 5.11 (dt, J ) 1.3, 10.0
Hz, 1H), 4.98-5.03 (m, 2H), 4.26 (ddt, J ) 1.7, 3.1, 4.5 Hz, 1H), 3.62
(dt, J ) 3.6, 9.0 Hz, 1H), 3.25 (dd, J ) 2.9, 8.6 Hz, 1H), 2.45 (m,
1H), 2.14 (m, 1H). 13C NMR (75 MHz, CD3OD): δ 139.9, 136.8, 117.2,
115.9, 77.0, 73.2, 72.2, 38.8. Anal. Calcd for C8H14O3: C, 60.74; H,
8.92. Found: C, 60.66; H, 9.41.
1,2,3,7,8-Pentadeoxy-5,6-O-isopropylidene-3-C-phenyl-D-manno-
oct-1,7-dienitol (12). Furanoside 1 (0.5 g, 1.59 mmol) was treated with
zinc (1.0 g, 15.3 mmol) and a solution of cinnamyl bromide (0.9 g,
4.6 mmol) in THF (10 mL) as described above for 11r to give after
flash chromatography 241 mg (55%) of 12, Rf ) 0.56 (pentane:Et2O
1,2,3,7,8-Pentadeoxy-L-xylo-oct-1,7-dienitol (8â). Rf ) 0.57 (Et2O).
1H NMR (500 MHz, CD3OD): δ 5.81-5.94 (m, 2H), 5.32 (ddd, J )
1.4, 1.6, 17.1 Hz, 1H), 5.18 (ddd, J ) 1.3, 2.1, 10.7 Hz, 1H), 5.10
(dddd, J ) 1.3, 1.7, 2.1, 17.1 Hz, 1H), 5.04 (dddd, J ) 1.0, 1.3, 2.1,
10.2 Hz, 1H), 4.17 (m, 1H), 3.68 (ddd, J ) 3.0, 6.0, 7.3 Hz, 1H), 3.29
(dd, J ) 3.0, 6.0 Hz, 1H), 2.28-2.38 (m, 2H). 13C NMR (75 MHz,
CD3OD): δ 139.1, 136.2, 117.2, 117.0, 76.5, 75.2, 72.3, 39.5.
Compounds 9R/â are the enantiomers of 8â/r.
1
) 4:1). [R]D +38.0 (c 1.0, CHCl3). H NMR (500 MHz, CDCl3): δ
7.31-7.34 (m, 2H), 7.21-7.25 (m, 3H), 6.24 (ddd, J ) 8.7, 10.2, 16.9
Hz, 1H), 6.09 (ddd, J ) 7.9, 10.2, 16.9 Hz, 1H), 5.34 (ddd, J ) 0.8,
1.6, 16.9 Hz, 1H), 5.33 (ddd, J ) 0.8, 1.6, 10.2 Hz, 1H), 5.19 (ddd, J
) 0.8, 2.0, 10.2 Hz, 1H), 5.10 (ddd, J ) 1.2, 2.0, 16.9 Hz, 1H), 4.50
(dd, J ) 7.1, 7.9 Hz, 1H), 3.96 (dd, J ) 3.5, 7.1 Hz, 1H), 3.47 (dd, J
) 7.3, 8.1 Hz, 1H), 2.23 (bd, J ) 6.7 Hz, 1H), 1.55 (s, 3H), 1.34 (s,
3H). 13C NMR (50 MHz, CDCl3): δ 141.3, 138.0, 134.2, 128.5, 128.0,
126.5, 119.5, 117.0, 108.4, 78.9, 77.4, 72.2, 53.3, 27.0, 24.7. Anal.
Calcd for C17H22O3: C, 74.42; H, 8.08. Found: C, 74.48; H, 8.08.
Acetylation gave 35: Rf ) 0.37 (pentane:Et2O ) 9:1). [R]D +47.7
(3S,5R)-Octa-1,7-dien-3,5-diol (10â). Rf ) 0.27 (pentane:Et2O )
1
1:1). [R]D +7.0 (c 1, CHCl3). H NMR(300 MHz, CDCl3): δ 5.93
(ddd, J ) 5.3, 10.6, 17.2 Hz, 1H), 5.82 (m, 1H), 5.30 (dt, J ) 1.5,
17.2 Hz, 1H), 5.11-5.18 (m, 3H), 4.48 (m, 1H), 4.40 (m, 1H), 2.24-
2.31 (m, 2H), 1.69-1.79 (m, 2H). 13C NMR (50 MHz, CDCl3): δ
140.5, 134.3, 118.2, 114.3, 70.4, 67.9, 42.0, 41.6. The stereochemistry
was determined after chemical correlation with the corresponding enyne;
see Table 1 in ref 5a.
1
(c 1.1, CHCl3). H NMR (300 MHz, CDCl3): δ 7.20-7.34 (m, 5H),
(3S,5S)-Octa-1,7-dien-3,5-diol (10r). Rf ) 0.29 (pentane:Et2O )
6.02 (dt, J ) 10.0, 16.8 Hz, 1H), 5.77 (ddd, J ) 7.2, 10.1, 17.0 Hz,
1H), 5.24-5.30 (m, 2H), 5.17 (dd, J ) 2.7, 9.4 Hz, 1H), 5.10 (dd, J )
1.7, 17.0 Hz, 1H), 5.06 (dd, J ) 1.8, 10.0 Hz, 1H), 4.47 (t, J ) 7.1
Hz, 1H), 3.93 (dd, J ) 2.7, 6.9 Hz, 1H), 3.69 (t, J ) 9.6 Hz, 1H), 2.02
(s, 3H), 1.57 (s, 3H), 1.31 (s, 3H). 13C NMR (50 MHz, CDCl3): δ
170.2, 140.4, 137.7, 133.0, 128.8, 128.0, 126.9, 118.8, 117.1, 108.7,
78.3, 76.4, 73.2, 52.7, 26.9, 25.5, 21.4. Anal. Calcd for C19H24O4: C,
72.13; H, 7.65. Found: C, 71.95; H, 7.57.
4-Benzylamino-1,2,3,4,7,8-hexadeoxy-5,6-O-isopropylidene-D-
ribo-oct-1,7-dienitol (13r). To a solution of furanoside 1 (1.0 g, 3.18
mmol) and benzylamine (0.7 mL, 6.41 mmol) in THF (20 mL) under
argon was added zinc (2.0 g, 30.6 mmol). The mixture was sonicated
at 40 °C for 3 h during which time allyl bromide (0.6 mL, 7.1 mmol)
was added dropwise. The sonication was continued for an additional 2
h until TLC indicated full conversion of 1, and the mixture was then
1
1:1). [R]D +5.2 (c 1, CHCl3). H NMR(300 MHz, CDCl3): δ 5.79-
5.88 (m, 2H), 5.27 (dt, J ) 1.4, 17.2 Hz, 1H), 5.10-5.19 (m, 3H),
4.39 (m, 1H), 3.95 (m, 1H), 2.24-2.31 (m, 2H), 1.58-1.76 (m, 2H).
13C NMR (50 MHz, CDCl3): δ 140.5, 134.1, 118.3, 114.5, 73.5, 71.2,
42.4, 42.4.
1,2,3,7,8-Pentadeoxy-5,6-O-isopropylidene-2-C-(isopropyloxycar-
bonyl)-D-ribo-oct-1,7-dienitol (11r). Zinc (1.00 g, 15.3 mmol) was
added to a solution of furanoside 1 (0.50 g, 1.59 mmol) in 2:1 THF:
H2O (12 mL). The mixture was sonicated at 40 °C under argon for 4
h during which time isopropyl R-(bromomethyl)acrylate (1.00 g, 4.83
mmol) was added dropwise by syringe pump. The sonication was
continued for an additional 2 h, and the mixture was then allowed to
shake at room temperature overnight and was then filtered through
Celite. The Celite was washed with Et2O (30 mL). The filtrate was